August 10, 2012
Takeda Pharmaceutical and its US subsidiary Millennium Pharmaceuticals announced on August 9 that they have decided to terminate a PIII trial for AMG 479 (ganitumab) in pancreatic cancer patients conducted in Japan following the decision of Amgen Inc. of the...read more